Warning This website requires JavaScript to function correctly. Please enable JavaScript in your web browser settings or white-list our domain "www.bbisolutions.com" if you use any plug-ins to block JavaScript.

Cancer and Tumour

Tumour Marker Antibodies

At BBI Solutions, we offer a range of monoclonal antibodies to cancer tumour markers to ensure the reliability and performance of your critical diagnostic assays.

BBI Solutions’ monoclonal antibodies are renowned as sensitive, cost-efficient products for assay developers, manufacturers and researchers worldwide. They are available in both small and bulk quantities depending on your individual needs.

Please contact our Customer Services Team directly to disuss your requirements on tel:+44 (0) 1495 363000 or alternatively you can submit an enquiry here.

Product description	Product code	Quantity
Human Osteopontin Monoclonal Antibody	MAB222P	1mg
Human Osteopontin, C-terminal Monoclonal Antibody	MAB197P	1mg
Human Osteopontin, N-terminal Monoclonal Antibody	MAB193P	1mg
Human Osteopontin, N-terminal Monoclonal Antibody	MAB194P	1mg
Human Osteopontin, N-terminal Monoclonal Antibody	MAB195P	1mg
Human Osteopontin, N-terminal Monoclonal Antibody	MAB196P	1mg
CA15-3 monoclonal antibody	BM236-K6A5	1mg
CA15-3 monoclonal antibody	BM236-V2G9	1mg
CA19-9 monoclonal antibody	BM238-G6C8	1mg
Free PSA Monoclonal Antibody	MAB296P	1mg
IGFBP3 Monoclonal Antibody	BM396-P6F9	1mg
IGFBP3 Monoclonal Antibody	BM396-V3C7	1mg
PSA Monoclonal Antibody	MAB291P	1mg
PSA Monoclonal Antibody	MAB292P	1mg

Cancer and Tumour

Providing the most important critical reagents for the preparation of calibrators and controls for cancer diagnosis.

Blockers

Our high performance blocking solutions used for electrophoretic and IVD applications.

ELISA Protein Stabilisers/Blockers/Diluents

A range of solutions designed to enhance and optimise IVD assay performance.

Substrates

Specific assay substrates to deliver the best assay sensitivity.

Antibodies FAQs

Our team are here to help! If you can’t find the answer you are looking for contact us.

Antibodies are a critical component of the defense arsenal assisting with identifying, capturing, and removing potential threats as well as protecting against future invasions. Antibodies are gammaglobulin proteins, predominantly referred to as immunoglobulins (Ig). A monomeric antibody is composed of two heavy chains and two light chains covalently linked together through disulfide bonds to generate a Y-shaped structure. This Y-shaped structure provides a bifunctional capacity: 1) antigen-binding through the Fab (antigen binding fragment), and 2) interaction with immune cells and proteins (fragment crystallizable or Fc) to initiate and regulate host defence mechanisms.

Polyclonal antibodies refer to a mixture of immunoglobulin molecules that are secreted against a particular antigen. They interact with different epitopes on the same antigen and their manufacture
does not require the use of hydbridomas.

Monoclonal antibodies refer to a homogenous population of antibodies that are produced by a single clone of plasma B cells. They interact with a particular epitope on the antigen and their manufacture requires the use of a hybridoma cell line.

This varies between products, please consult the example Certificate of Analysis for this information.

Yes, we manufacture many of our own products at our 2 manufacturing sites in Maine, USA and Porton Down, UK. All sites are ISO13485 certified.

BBI Solutions offers a growing portfolio of performance proven antibodies. With our in-house custom antibody expertise, customers can rely on BBI to be a trusted partner in antibody support, from secure
supply, to matched pair recommendations, and trouble shooting performance. Custom manufacturing lots and conjugation services are also value-added services available for most of our antibodies to suit your assay development needs.

A matched antibody pair consists of two antibodies, a capture and a detection antibody. In a matched pair, each antibody is specific for a different and non-interfering epitope of the antigen.

Hybridoma.

Rabbit, Goat and Sheep.

Roller bottle for lot sizes up to 1gram. Hollow fibre continuous perfusion system for lot sizes greater than 1 gram.

4-6 months for a monoclonal antibody and 3-4 months for a polyclonal

A discussion with a service team member will be necessary regarding this, however monoclonal development projects start at $20k and up.